Overview
Ju-suk Nam practices practicing medicine in Chuncheon, Republic of Korea.
Their clinical expertise encompasses Osteolysis Syndrome Recessive, Breast Cancer, Osteoporosis, and Gout.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ju-suk Nam
Is Ju-suk Nam a top-rated expert for Osteolysis Syndrome Recessive?
MediFind is an objective health platform that identifies experts based on real-world data. Ju-suk Nam is classified as an Experienced expert for Osteolysis Syndrome Recessive, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ju-suk Nam participate in research or clinical trials?
Yes. Ju-suk Nam has published 33 articles and abstracts on conditions like Osteolysis Syndrome Recessive. You can view a list of Ju-suk Nam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerNam isExperienced. Learn about Breast Cancer.
- GoutNam isExperienced. Learn about Gout.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Osteolysis Syndrome Recessive
- OsteoporosisNam isExperienced. Learn about Osteoporosis.